The world’s first intranasal vaccine, christened as iNcovacc, is based on a delivery vehicle, a virus, that causes the common cold (adenovirus vector). The spike...
Continue ReadingPharmaceutical major Cipla NSE 0.46 % announced that its wholly-owned UK subsidiary Cipla (EU) Limited has signed definitive agreements to invest 15 million euros in...
Continue ReadingApproving Sun Pharma’s proposal to amend the existing clinical trial protocol for the atypical antipsychotic Pimavanserin Capsules, the Subject Expert Committee (SEC) functional under the...
Continue ReadingCipla expects elevated capital expenditure on automation to continue for three more years, a senior official has said. The city-headquartered company started its investment journey...
Continue ReadingDrugmaker, Aurobindo Pharma Ltd, has announced that Subject Expert Committee (SEC) of the Central Drugs StandardControl Organization (CDSCO), in its minutes for the meeting held...
Continue ReadingHetero, a city-based leading pharmaceutical company announced the receipt of World Health Organisation Prequalification of Medicines Programme (WHO PQ) approval for its generic version of...
Continue ReadingGenomics India 2023, the 2- day extravaganza is here! A perfect amalgam of science and ideas that it is, our conference will discuss applications of...
Continue ReadingBiocon Limited announced the initiation of the clinical study of Itolizumab, a monoclonal antibody in patients with Ulcerative Colitis (UC) in India, in collaboration with...
Continue ReadingHyderabad-based-Biological E. Limited (BE) announced that it has received marketing approval from the Drugs Controller General of India (DCGI) for its Pneumococcal Conjugate vaccine (PCV14)...
Continue Reading